• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    iShares Biotechnology ETF (NQ:IBB)

    170.43 +1.58 (+0.94%)
    Streaming Delayed Price Updated: 10:08 AM EDT, Apr 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about iShares Biotechnology ETF

    News headline image
    Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
    The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital. 
    Via MarketBeat
    Topics ETFs Economy
    News headline image
    Biotech Breakout: Stocks for Your Watchlist
    The iShares Biotechnology ETF (IBB) has turned $140 resistance into support, positioning the overall sector for a potential breakout above $150. 
    Via MarketBeat
    Topics ETFs
    News headline image
    CPI Data Sparks Rally in Biotech Stocks
    Following lower-than-expected inflation data on Thursday, The biotech sector broke out above resistance, closing the week up 6%, far outperforming the market. 
    Via MarketBeat
    Topics ETFs Economy
    News headline image
    AbbVie Stock: A Perfect Dip for Investors to Buy
    ABBV stock is down over 3% to start the second half of the year; the stock may be overvalued in the short term but still offers value for long-term investors 
    Via MarketBeat
    Topics ETFs
    News headline image
    Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
    The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout. 
    Via MarketBeat
    Topics ETFs
    News headline image
    Gilead Sciences Stock Surges on HIV Treatment Trial Success
    Gilead Sciences (NASDAQ: GILD) saw its stock jump nearly 10% yesterday after announcing groundbreaking results from its HIV treatment trial. 
    Via MarketBeat
    News headline image
    Will the Biotech Sector Shift From Lagger to Leader?
    The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs. 
    Via MarketBeat
    Topics ETFs
    News headline image
    Biotech Sector Nears Breakout: Will it Outperform in Q2?
    The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gains 
    Via MarketBeat
    Topics ETFs
    News headline image
    Will the Biotech sector sustain its momentum in 2024?
    The iShares Biotechnology ETF (NASDAQ: IBB) emerged as a standout star, closing the first day of the year with a solid upswing of nearly 4%. 
    Via MarketBeat
    Topics ETFs
    News headline image
    MarketBeat Week in Review – 12/4 - 12/8
    Stocks finished in the green to close the week; investors believe the jobs report will allow the Fed to leave interest rates unchanged when they meet next week 
    Via MarketBeat
    Topics Economy
    News headline image
    3 biotech powerhouses poised to thrive amid sector rebound
    If the newfound support and uptrend in the biotech sector last, as the new year quickly approaches, the biotech sector could shift from lagger to leader. 
    Via MarketBeat
    Topics ETFs
    News headline image
    Biotech reversal confirmed: what's ahead for the IBB?
    The recent reversal and reclaim of the significant $124 support level in the IBB holds importance, indicating a potential shift in momentum. 
    Via MarketBeat
    Topics ETFs
    News headline image
    3 Strong Biotech Performers To Watch As Sector Nears Breakout
    As the IBB ETF nears a potential breakout, watch for strong performers like Regeneron Pharmaceuticals, Vertex, and Exelixis to continue outperforming. 
    Via MarketBeat
    Topics ETFs
    News headline image
    Moderna: Declining Performance And Relative Weakness
    Moderna's value has declined by over 75% from its peak as the world moves on from the COVID-19 pandemic, leading to concerns about its investment appeal. 
    Via MarketBeat
    Topics ETFs
    News headline image
    Is the Biotech Industry (IBB) Poised For A Major Breakout?
    The current consolidation in the IBB signals a potential breakout might be looming as key moving averages have converged within a contracted price range. 
    Via MarketBeat
    Topics ETFs
    News headline image
    Tarsus Added to NASDAQ Biotechnology Index
    From Tarsus Pharmaceuticals, Inc
    Via GlobeNewswire
    BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
    The world of biotech is having what some are calling a golden age. Many companies are presenting new and innovative drugs to the FDA for approval and later the public for consumption. Smart Beta EFTs... 
    Via TheNewswire.com
    Topics Stocks
    News headline image
    BlackRock Announces Product Updates to Two iShares ETFs
    From BlackRock, Inc.
    Via Business Wire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.